Literature DB >> 16885020

Controlling the elongation phase of transcription with P-TEFb.

B Matija Peterlin1, David H Price.   

Abstract

The positive transcription elongation factor b (P-TEFb) is a cyclin-dependent kinase that controls the elongation phase of transcription by RNA polymerase II (RNAPII). This process is made possible by the reversal of effects of negative elongation factors that include NELF and DSIF. In complex organisms, elongation control is critical for the regulated expression of most genes. In those organisms, the function of P-TEFb is influenced negatively by HEXIM proteins and 7SK snRNA and positively by a variety of recruiting factors. Phylogenetic analyses of the components of the human elongation control machinery indicate that the number of mechanisms utilized to regulate P-TEFb function increased as organisms developed more complex developmental patterns.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16885020     DOI: 10.1016/j.molcel.2006.06.014

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  622 in total

1.  Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.

Authors:  Won-Kyung Cho; Moon Kyoo Jang; Keven Huang; Cynthia A Pise-Masison; John N Brady
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Inositol phosphate kinase Vip1p interacts with histone chaperone Asf1p in Saccharomyces cerevisiae.

Authors:  Shigehiro Osada; Kiyoto Kageyama; Yuji Ohnishi; Jun-Ichi Nishikawa; Tsutomu Nishihara; Masayoshi Imagawa
Journal:  Mol Biol Rep       Date:  2011-12-09       Impact factor: 2.316

3.  Interactions between DSIF (DRB sensitivity inducing factor), NELF (negative elongation factor), and the Drosophila RNA polymerase II transcription elongation complex.

Authors:  Anamika Missra; David S Gilmour
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-04       Impact factor: 11.205

Review 4.  RNA polymerase II elongation control.

Authors:  Qiang Zhou; Tiandao Li; David H Price
Journal:  Annu Rev Biochem       Date:  2012-03-09       Impact factor: 23.643

5.  Control of the RNA polymerase II phosphorylation state in promoter regions by CTD interaction domain-containing proteins RPRD1A and RPRD1B.

Authors:  Zuyao Ni; Jonathan B Olsen; Xinghua Guo; Guoqing Zhong; Eric Dongliang Ruan; Edyta Marcon; Peter Young; Hongbo Guo; Joyce Li; Jason Moffat; Andrew Emili; Jack F Greenblatt
Journal:  Transcription       Date:  2011 Sep-Oct

Review 6.  Transcriptional activators and activation mechanisms.

Authors:  Jun Ma
Journal:  Protein Cell       Date:  2011-12-17       Impact factor: 14.870

7.  Transcription control by long non-coding RNAs.

Authors:  Tyler Faust; Alan Frankel; Iván D'Orso
Journal:  Transcription       Date:  2012-03-01

8.  Dynamic Change of Transcription Pausing through Modulating NELF Protein Stability Regulates Granulocytic Differentiation.

Authors:  Xiuli Liu; Aishwarya A Gogate; Melodi Tastemel; Venkat S Malladi; Huiyu Yao; Kim Nguyen; Lily Jun-Shen Huang; Xiaoying Bai
Journal:  Blood Adv       Date:  2017-08-08

9.  The structure of CDK4/cyclin D3 has implications for models of CDK activation.

Authors:  T Takaki; A Echalier; N R Brown; T Hunt; J A Endicott; M E M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

10.  Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.

Authors:  Rong Chen; William G Wierda; Sherri Chubb; Rachael E Hawtin; Judith A Fox; Michael J Keating; Varsha Gandhi; William Plunkett
Journal:  Blood       Date:  2009-02-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.